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URBAN PREVALENCE OF EPILEPSY
Populational study in São José do Rio Preto,
a medium-sized city in Brazil 
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ABSTRACT - The aim of this study was to determine the prevalence of epilepsy in the urban population of São José do Rio Preto.
This is a medium-sized city of 336000 inhabitants, located in the northwest of the state of São Paulo, Brazil. Method:A cross-sec-
tional epidemiological investigation with a randomized sample was performed in two phases, a screening phase and a confirma-
tion of the diagnosis phase. The gold standard was a clinical investigation and neurological examination. The chi-square test was
used in analysis of the results and p-value value < 0.05 was considered significant. Prevalence was calculated with 95% confidence
interval. Results: The study sample size was 17293 individuals, with distributions of gender, age, and race similar to the general
population.The prevalence per 1000 inhabitants of epilepsy was 18.6, of these 8.2 were active, defined as at least one seizure with-
in the last two years. The prevalence per 1000 inhabitants for the age groups (years) was 4.9 (0-4), 11.7 (5-14), 20.3 (15-64) and
32.8 (65 or over). Conclusion: Prevalence of both accumulated and active epilepsy was elevated, comparable to other developing
nations, in particular those of Latin America. However, the prevalence of epilepsy in childhood was low, whilst in aged individuals
it was high similar to industrialized nations.
KEY WORDS: epilepsy, epidemiology, prevalence, Latin America.
Prevalência urbana da epilepsia: estudo populacional em São José do Rio Preto - cidade de médio porte do Brasil 
RESUMO - Antecedentes: O objetivo deste estudo foi determinar a prevalência da epilepsia na população urbana de São José do
Rio Preto, com 336000 habitantes, localizada no noroeste do Estado de São Paulo/ Brasil. Método: O estudo populacional, tipo
corte transversal, em amostra aleatória, constituiu-se de uma fase de rastreamento, mediante um questionário. O padrão ouro para
confirmação diagnóstica foi a história clínica e o exame neurológico. Os testes do χ2 e intervalo de confiança de 95% (IC-95%)
foram usados para análise dos resultados, tendo sido considerados significantes os de valor p≤ 0,05. Resultados:A amostra estu-
dada foi de 17293 pessoas, cuja distribuição quanto ao sexo, à faixa etária e à raça foram semelhantes à da população em geral.
A prevalência de epilepsia por 1000 hab. foi 18,6, sendo 8,2 para ativa considerando-se, pelo menos, uma crise no período dos últi-
mos 2 anos. A prevalência na faixa etária de 0 a 4 anos foi 4,9, de 5 a 14, 11,7; de 15 a 64, 20,3; e acima dos 65 anos foi 32,8.
Conclusão: As prevalências de epilepsia acumulada e ativa foram elevadas, semelhantes às dos países em desenvolvimento, em
particular, aos da América Latina. A prevalência de epilepsia na infância foi baixa, enquanto que nos idosos foi elevada, semel-
hantes às observadas em países desenvolvidos. Estes resultados são relevantes no planejamento de medidas sanitárias, adequação
ao tratamento da população, considerando a alta prevalência encontrada, para minimizar o impacto da epilepsia na população.
PALAVRAS-CHAVE: epilepsia, epidemiologia, prevalência, América Latina.
Epilepsy is one of the most common serious chronic disor-
der1 and it causes suffering for patients and families2,3.
Epidemiological studies of the prevalence of epilepsy have pro-
duced results that vary from 1.5/10004 to 57/10005 inhabitants.
The discrepant results are explained by different etiologic risk
factors and distinct methodologies employed1,4-10.
A direct approach among the members of the communi-
ty is the best method to estimate the rate of epilepsy in devel-
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oping countries, as quality of data required may not be avail-
able in the form of medical records4,8,10-15. Brazil is a country
of continental dimension located in South America with approx-
imately 170 millions inhabitants. Two epidemiological stud-
ies were carried out in Brazil. Marino et al., (1986)16 found a
prevalence of epilepsy of 11.9/1000 in São Paulo city. However,
the study does not make distinction between active and inac-
tive epilepsy. Fernandes et al., (1992)17 applied a screening ques-
tionnaire for epilepsy in Porto Alegre city and found a preva-
lence of 16.5/1000 for active and 20.3/1000 for inactive epilep-
sy.
This study aims to estimate the prevalence of active and
accumulated epilepsy in relation to the distribution of age
groups, epileptic seizure types and syndromes in a medium sized
urban city in southeastern Brazil.
METHOD
Demographic data - This survey was carried out in São José do
Rio Preto (SJRP) a city located in the northwest of the State of São
Paulo, Brazil. The urban population according to the national census
(IBGE)18 is 336000 inhabitants where 51.3% are women. The distri-
bution in percentages of the inhabitants for the age groups (years)
is 7.3% (0-4), 17.3% (5-15), 68.8% (15-64), and 6.6% (65 or over).
Questionnaire - We first constructed a questionnaire (shown in
the Appendix 1), composed of eight questions which were modified
from the guidelines of the World Health Organization (WHO), and sim-
ilar to the nine questions used by Placencia et al.8. This was applied
in 100 consecutive patients with epilepsy in the outpatient clinic of
the Hospital de Base (HB) Medical School in São José do Rio Preto,
with the aim of improving the language and cultural terminology.
Pilot study - A pilot study was carried out to validate the ques-
tionnaire.
The chosen suburb, for this phase, was São Deocleciano (2001),
with 1500 inhabitants9.A cross-sectional house-to-house survey was
performed using this questionnaire with the aim of screening indi-
viduals with a possible history of epileptic seizures.A total of 20 stu-
dents from the School of Economics of Dom Pedro Faculty performed
this task, identifying the houses as positive or negative according to
the questionnaire. Positive cases were considered with at least one
affirmative response.
In the diagnostic confirmation phase, a specialist with experience
in epilepsy visited all cases, both positive and negative to make a clin-
ical record and a physical examination.The aim of this phase was to
determine the true and false positive and negative cases, to assess
the sensitivity and specificity of the questionnaire, previously described
by Borges et al. elsewhere9. Briefly, questionnaire presented a sen-
sitivity of 95.83% and a specificity of 97.8%.The total number of par-
ticipants in the survey was 1025 where 46.9% were men. The first
three questions produced the majority of the affirmative responses
and were responsible for the majority of the true positive cases. The
other questions produced the greatest number of false positive cas-
es.
Field study - A large-scale cross-sectional population-based sur-
vey using a random sample and segmented depending on the fifteen
administration regions of the city was planned.The sample size was
defined by standard techniques using mathematical equations with
correlation for finite populations19,20. The study was done in two
phases, using the same strategy used in the pilot study: a screening
phase, applying the questionnaire, and a confirmation of the diag-
nosis phase, done by a clinical investigation and neurological exam-
ination.
First phase - Five professionals trained in home surveys to iden-
tify the houses with positive and negative cases applied the ques-
tionnaire door-to-door in a randomly chosen sample.
Second phase - The diagnostic confirmation was performed by
only one professional (MAB) in all positive cases.The information of
these people was crosschecked with the archives of HB whenever avail-
able. Cases with doubts or no previous diagnoses were submitted to
complementary exams as individual basis needed to confirm the
diagnosis. False positive cases were determined by a mathematical
model from the validation of the pilot study.
Diagnostic validation criteria of epilepsy - The guidelines of the
International League Against Epilepsy (ILAE)21,22 were adopted as the
criteria for the classification of epileptic seizures in the preparation
of the standard protocol. Only those individuals who had at least two
non-provoked seizures at an interval of at least 24 hours between
them were considered.
The etiology of the epilepsy was classified according to the pro-
posal of the Commission on Epidemiology and Prognosis of ILAE15
and Hauser et al.2 The etiology of epilepsy was classified into three
groups, as follows: Idiopathic seizure - epilepsy that fulfills criteria
of one of the epileptic syndromes (presumably genetic) which occur
in the absence of any neurological anomalies; Symptomatic - epilep-
sy that occurs in the presence of a remote aggression or to a previ-
ous disorder that is recognized as an associated risk factor before
the first seizure; Possible symptomatic (Cryptogenic) - epilepsy in the
absence of an identifiable cause and the patient does not meet the
criteria for idiopathic epileptic syndrome2.
Active epilepsy (Eat) at 2, 3, 4, and 5 years was defined as the
occurrence of at least one seizure in one of these time intervals pre-
ceding the survey, independent of the use or not of antiepileptic drugs.
Accumulated prevalence (Eac) was the total prevalence, composed of
both active and inactive epileptic seizures. Non-provoked and acute
symptomatic (provoked) seizures and non-epileptic events were
defined, according to Hauser et al.2. All seizures and events that did
not fit into these criteria and epilepsy definitions were excluded.
The data was analyzed using Microsoft Excel and MINITAB.The chi-
square test was used in the analysis of the gender and age of the indi-
viduals. A 95% confidence interval (95% CI) was calculated for the
prevalence estimates.
RESULTS
The sample size was composed of 7655 domiciles.We were able
to access 4815 houses, as the others were closed, after at least three
returns at each address. Only 11 refusals occurred.
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Appendix 1
This questionnaire was constructed and tested in Portuguese.
House nº  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., Number of inhabitants [   ] male [   ]; female [  ]
Name  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Age  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Street . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., nº  . . . . . . . . . . . . . . .Apart nº  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Suburb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Phone:  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1. Do  you  have  o r  have  you  had  se i zu re s  ( a t t a ck s, f i t , convu l s i on )  i n  wh i ch  you  l o s t  cons c i ousnes s  and  f a l l  s udden l y?  
In this house, does anyone have? YES[  ]; NO[  ].
2. Do  you  have  o r  have  you  had  se i zu re s  i n  wh i ch  you  l o se  con tac t  w i th  r ea l i t y  ( su r round ings )  and  become  “o f f  t he  a i r”?
In this house, does anyone have? YES[  ]; NO[  ].
3. Do  you  have  o r  have  you  had  se i zu re s  i n  wh i ch  you  have  uncon t ro l l ab l e  j e r k s / j o l t s  o f  t he  a rms, l eg s, mou th  o r  t he
head twisted to the side? In this house, does anyone have? YES[  ]; NO[  ].
4. Do  you  have  o r  have  you  had  fa in t ing  ep i sodes  and  on  recover ing  your  senses  you  not i ce  that  you  u r ina ted  o r  de fecated
in your clothes by accident? In this house, does anyone have? YES[  ]; NO[  ].
5. Do you have or have you had seizures in which you feel a bad sensation such as “sinking” or a “knot” in the stomach which r i s e s  t o  t he
throat and after you fall unconscious? Following this, witnesses say that you fidgeted with your clothes, chewed, or looked at a distant point?
In this house, does anyone have these seizures? YES[  ]; NO[  ].
6. D id  a  doc to r  o r  hea l t h  wo rke r  o r  e ven  membe r s  o f  you r  f am i l y  e ve r  men t i on  to  you  tha t  you  had  f eb r i l e  convu l s i ons
in your childhood or during any serious disease? In this house, does anyone have these seizures? YES[  ]; NO[  ].
7. Do  you  have  sudden  j o l t s  s im i l a r  t o  a  “ shock” i n  t he  a rms  ( you  d rop  th i ngs )  o r  l eg s  w i th  o r  w i thou t  f a l l i ng , ma in l y
in the morning? YES[  ]; NO[  ].
8. Is there anyone from this house with epilepsy in an asylum in São José do Rio Preto? YES[  ]; NO[  ].
POSITIVE [     ] NEGATIVE [     ]
NOBODY ANSWERED THE DOOR [  ] HOUSE LOCKED [  ] UNINHABITED [  ]
REFUSAL TO PARTICIPATE [  ]
The survey included 17293 inhabitants of 4804 domiciles of the
city. The questionnaire was positive for at least one question of 894
people living in 890 dwellings. These individuals were examined by
the neurologist and 308 cases were confirmed as having epilepsy. It
was noticed that 40% of the identified people with epilepsy regu-
larly attend or, at least, have been treated in the outpatient’s clinic
of the HB. Furthermore, all had at least an EEG, 80% had a brain CT
scan, and 10% a brain MRI.
A total of 321 cases of epilepsy were evidenced, including 308
true positive cases and 13 false negative cases mathematically pro-
jected from the results of the research instrument validation (sensi-
tivity of 95.8 [95% CI: 94.6 - 97])9.The average age of confirmed cas-
es in the study was 38.4 (range from 1 to 84 years). The female gen-
der accounted for 165 cases (51.3%), which is a similar ratio to the
sample population, and the general population of São José do Rio
Preto (p-value = 0.99).
Prevalence -The results showed that the accumulated prevalence
of epilepsy was 18.6/1000 inhabitants (95% CI:16.6 - 20.6).
Prevalence and age range - The accumulated prevalence of
epilepsy was not equally distributed among the four age groups
studied, as can be seen in Table 1 (p-value = 0.0001).
Prevalence of active epilepsy (Pat) - The active epilepsy was ana-
lyzed taking into account at least one seizure in the last 2, 3, 4 and
5 years. The results are shown in Table 2. The prevalence of inactive
epilepsy was obtained by subtracting the active epilepsy prevalence
from the accumulated and it was studied in respect to the identical
time intervals.
Prevalence of types of epilepsy according to the ILAE classifica-
tion - The prevalence of epilepsy according to the clinical and elec-
troencephalographic classification of epileptic seizures (ILAE)21 is
shown in Table 3.
Prevalence of epileptic syndromes according to the ILAE classifi-
cation - The prevalence of epilepsy considering its syndromic classi-
fication according to ILAE (1989)22 was analyzed and the results are
shown in Table 4.
DISCUSSION
In general, the use of the questionnaire was well accept-
ed by the population and refusal to collaborate was minimal.
In various residences the interviewers were unsuccessful in talk-
ing to the inhabitants. The investigator (MAB) himself went
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to some of these houses and verified that the reason for this
was fear of robbers (the individual was alone at home) and
the inconvenience of politicians, preachers, salesmen and beg-
gars. In lower economic class neighborhoods, individuals were
more collaborative to give information about diseases in the
family. In the upper class communities this was more com-
plicated and to access them, we asked the help of their neigh-
bors to inform them about the research and also we contact-
ed them by previous telephone calls.
Confirmation of diagnosis, based on clinical records and
a physical examination, was made by a neurologist  (MAB) with
experience in epilepsy. As diagnosis of epilepsy is sometimes
difficult23, care was taken to crosscheck the information with
records from the reference service of the HB when the data
were available.These details increased the credibility and the
reliability of the results, mainly in respect to classification of
seizures and of causes of disease. This procedure has fre-
quently been used by other authors11,12,24,16.
The accumulated and active (2, 3, 4, and 5 years) prevalence
of epilepsy in the city of São José do Rio Preto are high and
overall they are comparable to prevalences estimated in oth-
er developing countries5,8,13,22, specifically to Latin American
countries. Placencia et al.8 reviewed 48 studies published in
the 70s, 80s and 90s about prevalence using different method-
ologies.They found a high prevalence particularly in develop-
ing countries, although in some countries such as India25 and
Table 1. Prevalence of accumulated epilepsy with respect to age groups*.
Age range Prevalence
(years) /1000 inhabitants 95%;CI 
0 to 4 4.9 3.9 - 6.0
5 to 14 11.7 10.0 - 13.3
15 to 64 20.3 18.2 - 24.4
65 or more 32.8 30.1 - 35.4
Total 18.6 16.6 - 20.6
*, p-value < 0.0001
Table 2. Prevalence of active and inactive epilepsy with respect to at least one seizure in the last
2, 3, 4 and 5 years.
Last seizure Active epilepsy Inactive epilepsy
(years) Prevalence 95%;CI Prevalence 95%;CI
2 8.2 6.8 - 9.5 10.4 8.9 - 11.9
3 10.9 9.3 - 12.4 7.7 6.4 - 9.0
4 12.6 10.9 - 14.3 5.9 4.8 - 7.1
5 13.3 11.6 - 15.0 5.3 4.2 - 6.4
Nigeria11,12 there are regions in which the prevalence is low,
similar to what is observed in developed countries26.
The accumulated prevalence was not associated with gen-
der, as had been observed in the majority of surveys, both in
developed 2 and developing countries5,16,21. The active epilep-
sy rate was high with all the period intervals considered (2,
3, 4 and 5 years), with a great increase in the prevalence from
two to five-year period.This may be explained by the difficul-
ty of some patients in maintaining the adherence to treatment,
already suggested by Zielinski in a study from Poland27. Ho-
wever, this increase of prevalence over the five-year period found
in this study, is more accentuated, but no significant, than that
in developed countries which supports findings by Fernandes
et al. in Brazil17,28 and Aziz et al. in Pakistan24.
This design did not specifically consider the interval in
which the patients did not take medicine, the so-called treat-
ment gap. However, in respect to the occurrence of at least
one seizure in the last 5 years, only 28.5% of the individuals
with epilepsy controlled their seizures, suggesting that the treat-
ment gap is high. These alarming numbers are relevant and
of great importance to the local public health.
The five age groups studied, two of which are related to chil-
dren, took into consideration the period in which the main
symptoms of idiopathic epilepsy appear29. In this study, a strong
association between the prevalence of epilepsy and age was
demonstrated. For instance, the prevalence of active epilepsy
(five-year period) among children from 0 to 14 years is low,
comparable to the prevalence found by Hauser et al.2 in the
city of Rochester in the USA and Kurtz et al.30 in Britain. In gen-
eral, the recent epidemiological studies have pointed to a low
rate in this age group, except for a study in India31 in which
the prevalence was high, probably due to malnutrition, peri-
natal problems and infections.
The prevalence of active epilepsy in school children (5 to
14 years) in this study had a significant increase similar to stud-
ies from the industrialized world2.This stems from the appear-
ance of idiopathic epilepsy in infancy. However, the prevalence
of epilepsy in this age group was significantly lower than the
rate found in Chile32, which was probably due to their inclu-
sion of febrile seizures as epilepsy in their study.
The prevalence of accumulated epilepsy in adults was high,
similar to the rates found in other developing countries in Latin
America5,16,28,33. Thus, the most important risk factors acting in
developing countries may have influenced this age group in the
past and perhaps still have an influence with diseases such as
neurocysticercosis, infectious diseases and sanitary health prob-
lems34-37.
The prevalence of accumulated epilepsy in the elderly is high.
According to publications, this rate is falling in industrialized coun-
tries2,11 and even more so in underdeveloped countries8,13, a fact
that is difficult to explain. Another fact observed in relation to
the accumulated prevalence in SJRP, among the elderly, was the
significant tendency to be greater then in developed coun-
tries38,39. This is probably due to an overlapping of risk factors
found both in developed and in developing countries40.
The partial seizures were the most common, however with
an elevated prevalence.These results are similar to those of sev-
eral recent researches2,40-43. The explanation proposed for this
fact may be the low rate of remission of partial seizures.Another
aspect that may cause an overestimation of this prevalence is
neurocysticercosis a risk factor which is endemic in this region35,36.
Idiopathic seizures have a low prevalence, significantly low-
er than the results of other recent investigations in Europe43-
45. Perhaps this fact is due to the disproportional increase in
the prevalence of cryptogenic and symptomatic epilepsy, a
characteristic of underdeveloped and developing countries.Thus,
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if patients with epilepsy caused by avoidable circumstances
were ignored in this study, the prevalence of symptomatic
epilepsy would probably be significantly higher and therefore
similar to results found in Europe. The percentage of sympto-
matic seizures was similar to the recent studies23,43,46, per-
haps due to the technological resources now available here.
The results of this research demonstrated that the preva-
lence of epilepsy in São José do Rio Preto is high among
young people, adults and the elderly but low among children.
This reflects the influences of risk factors from both industri-
alized and underdeveloped societies. Also more than two
thirds of the individuals with epilepsy are without control of
their seizures, in such a way that government public health
campaigns are urgently required, with the aim of socio-eco-
nomic inclusion of this important group of the population.
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